Fusaric (5-butylpicolinic) acid, an inhibitor of dopamine beta-hydroxylase, affects serotonin and noradrenaline.
D000818:Animals; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000032:analysis; D008297:Male; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors*; D008995:Monoamine Oxidase / Q000032:analysis; D009638:Norepinephrine / Q000378:metabolism*; D010300:Parkinson Disease / Q000188:drug therapy; D010848:Picolinic Acids / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000378:metabolism*
D010848:Picolinic Acids; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D006899:Mixed Function Oxygenases; D008995:Monoamine Oxidase; D004298:Dopamine; D009638:Norepinephrine